Cliff Stocks: Founder and CEO of OncoResponse

Portrait of Cliff Stocks

Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

Alexion Pharmaceuticals

Rare Heroes

Silicon Therapeutics employee at microscope
Silicon Therapeutics

A Quantum Leap in Medicine

Atrium Banner
Alexion Pharmaceuticals

Atrium Corporate Intranet